ChromoTek
Loading ...
- Chemicals/Pharmaceuticals
- Steady Stage
- Manufacturing
- B2B
- 2008
-
11-50 Employees
- Found
- Martinsried, DE
- Login required
- ChromoTek GmbH
-
Bayern
Profile is not claimed et
This profile is created by the Startbase Analyst Team. If you are a team member of this company you can claim the profile in order to make changes to it.
Is this your company?
Claim profile
About the Team
Are you part of this team?
Marion Jung
Geschäftsführerin
Alumni
| 2008 - 2011 |
Ulrich Rothbauer Geschäftsführer |
News about ChromoTek
Comprehensive Startup Listings:
Startups from Planegg Startups from Bayern Startups from DeutschlandRecent mentions of ChromoTek in podcasts & videos:
Jobs at ChromoTek:
Related companies
Startup
2004
Leipzig
C-Lecta
Development, production, marketing and trading of biotechnological products and services.
Startup
2000
Tübingen
CureVac
Developing medicines to protect and improve people's lives – by enabling the body to make its own prophylactic and therapeutic drugs.
Startup
2016
Hannover
Cardior Pharmaceuticals
Development and clinical validation of noncoding RNA therapeutics for patients with myocardial infarction and heart failure.
Startup
2015
Planegg
Thermosome
Drug development company focused on targeted tumor therapy combined with immune stimulation for improved cancer therapy.
Startup
2016
Hamburg
Statista
Provider of market and consumer data, especially in the B2B sector.
Other Startups nearby
Startup
2011
Martinsried
Dust BioSolutions
Dust BioSolutions is a start-up company focusing on industrial applications of biotechnology.
Startup
2010
Martinsried
GNA Biosolutions
Developing instruments, OEM modules and tests for the ultrafast, molecular biological detection of a wide range of pathogens. The core is a specially developed technology called laser PCR.
Startup
2019
Planegg-Martinsried
Eisbach
Development of drugs targeting chromatin regulatory mechanisms important for tumors.
Startup
2010
Planegg
Lindis Biotech
Development of Triomab® antibodies - a new class of T-cell activating bispecific antibodies that enable the immune system to transform malignant cancers into treatable and potentially curable diseases.
Startup
2013
Planegg
Bind-X
Industrial applications in the field of biotechnology.
FYI: English edition available
Hello my friend, have you been stranded on the German edition of Startbase? At least your browser tells us, that you do not speak German - so maybe you would like to switch to the English edition instead?
FYI: Deutsche Edition verfügbar
Hallo mein Freund, du befindest dich auf der Englischen Edition der Startbase und laut deinem Browser sprichst du eigentlich auch Deutsch. Magst du die Sprache wechseln?